140 | Humans |
128 | COVID-19 |
123 | SARS-CoV-2 |
111 | Coronavirus Infections |
89 | Pandemics |
81 | Betacoronavirus |
78 | Pneumonia, Viral |
61 | Animals |
52 | Male |
47 | Female |
43 | Spike Glycoprotein, Coronavirus |
35 | Middle Aged |
35 | Genome, Viral |
30 | Adult |
27 | Phylogeny |
26 | Mutation |
22 | Angiotensin-Converting Enzyme 2 |
20 | Genetic Variation |
19 | Aged |
18 | China |
17 | RNA, Viral |
14 | Infectious bronchitis virus |
13 | Poultry Diseases |
13 | Genotype |
13 | Chickens |
13 | Antibodies, Neutralizing |
12 | Virus Replication |
12 | Protein Binding |
12 | Antibodies, Viral |
11 | Porcine epidemic diarrhea virus |
11 | Peptidyl-Dipeptidase A |
11 | High-Throughput Nucleotide Sequencing |
11 | Evolution, Molecular |
11 | Chlorocebus aethiops |
10 | Young Adult |
10 | Virus Internalization |
10 | Viral Vaccines |
10 | Vero Cells |
10 | Swine |
10 | Polymorphism, Single Nucleotide |
10 | Mice |
10 | Binding Sites |
10 | Antiviral Agents |
10 | Adolescent |
9 | Swine Diseases |
9 | Models, Molecular |
8 | Serine Endopeptidases |
8 | Receptors, Virus |
8 | Protein Domains |
7 | Sequence Analysis, RNA |
7 | Protein Conformation |
7 | Lung |
7 | Cohort Studies |
7 | COVID-19 Vaccines |
7 | Amino Acid Substitution |
7 | Amino Acid Sequence |
6 | Whole Genome Sequencing |
6 | Viral Proteins |
6 | Viral Nonstructural Proteins |
6 | Treatment Outcome |
6 | Severity of Illness Index |
6 | Recombination, Genetic |
6 | Middle East Respiratory Syndrome Coronavirus |
6 | Host-Pathogen Interactions |
6 | HEK293 Cells |
6 | Guillain-Barre Syndrome |
6 | Genomics |
6 | Genetic Predisposition to Disease |
6 | Disease Outbreaks |
6 | Cell Line |
6 | Aged, 80 and over |
5 | Viral Envelope Proteins |
5 | Quarantine |
5 | Prevalence |
5 | Gene Expression |
5 | Feces |
5 | Europe |
5 | Disease Models, Animal |
5 | Diarrhea |
5 | Coronavirus |
5 | Computational Biology |
5 | Base Sequence |
4 | Virulence |
4 | Viral Tropism |
4 | Vaccines, Attenuated |
4 | Vaccination |
4 | United States |
4 | Time Factors |
4 | Surveys and Questionnaires |
4 | Specific Pathogen-Free Organisms |
4 | Sequence Deletion |
4 | Risk Factors |
4 | Real-Time Polymerase Chain Reaction |
4 | Protein Interaction Domains and Motifs |
4 | Open Reading Frames |
4 | Molecular Epidemiology |
4 | Molecular Docking Simulation |
4 | Miller Fisher Syndrome |
4 | Italy |
4 | Immunization |
4 | Hospitalization |
4 | Gene Frequency |
4 | Disease Management |
4 | Databases, Genetic |
4 | Coronavirus Envelope Proteins |
4 | Chiroptera |
4 | Child |
4 | Child, Preschool |
4 | Alleles |
3 | Viral Load |
3 | United Kingdom |
3 | Transcription, Genetic |
3 | Species Specificity |
3 | Social Isolation |
3 | Sequence Analysis, DNA |
3 | Sequence Alignment |
3 | Selection, Genetic |
3 | SARS Virus |
3 | Reverse Transcriptase Polymerase Chain Reaction |
3 | Retrospective Studies |
3 | Respiratory Distress Syndrome |
3 | RNA-Dependent RNA Polymerase |
3 | RNA-Binding Proteins |
3 | Public Policy |
3 | Protein Stability |
3 | Protein Multimerization |
3 | Protein Engineering |
3 | Prognosis |
3 | Pregnancy |
3 | Molecular Sequence Annotation |
3 | Molecular Dynamics Simulation |
3 | Mice, Inbred BALB C |
3 | Mesocricetus |
3 | Linkage Disequilibrium |
3 | Kinetics |
3 | Kidney Transplantation |
3 | India |
3 | Immunoglobulin G |
3 | Immunogenicity, Vaccine |
3 | Immunity, Innate |
3 | Genome-Wide Association Study |
3 | Genetic Fitness |
3 | Gene Expression Profiling |
3 | Furin |
3 | Epidemiological Monitoring |
3 | England |
3 | Disease Progression |
3 | Dipeptidyl Peptidase 4 |
3 | Diagnosis, Differential |
3 | Cysteine Endopeptidases |
3 | Cryoelectron Microscopy |
3 | Cricetinae |
3 | Coronavirus 3C Proteases |
3 | Communicable Disease Control |
3 | Cells, Cultured |
3 | Basic Reproduction Number |
3 | Asia |
3 | Antibodies, Monoclonal |
3 | Alveolar Epithelial Cells |
3 | Alphacoronavirus |
3 | Adjuvants, Immunologic |
2 | Whole Exome Sequencing |
2 | Waste Water |
2 | Vitamins |
2 | Virus Cultivation |
2 | Virion |
2 | Viral Matrix Proteins |
2 | Ultrasonography |
2 | Travel-Related Illness |
2 | Trachea |
2 | Toll-Like Receptors |
2 | Toll-Like Receptor 7 |
2 | Toll-Like Receptor 3 |
2 | Th1 Cells |
2 | T-Lymphocytes |
2 | Spain |
2 | Single-Domain Antibodies |
2 | Single-Cell Analysis |
2 | Signal Transduction |
2 | Severe Acute Respiratory Syndrome |
2 | Serial Passage |
2 | Sequence Analysis |
2 | Sequence Analysis, Protein |
2 | Respiratory Tract Infections |
2 | Respiration, Artificial |
2 | Recombinant Proteins |
2 | Receptors, Coronavirus |
2 | RNA, Messenger |
2 | Quantitative Trait Loci |
2 | Proteomics |
2 | Prospective Studies |
2 | Polymorphism, Genetic |
2 | Point Mutation |
2 | Phylogeography |
2 | North America |
2 | Nervous System Diseases |
2 | Nasopharynx |
2 | Mutation, Missense |
2 | Mutagenesis |
2 | Murine hepatitis virus |
2 | Molecular Typing |
2 | Molecular Diagnostic Techniques |
2 | Mice, Transgenic |
2 | Mice, Inbred C57BL |
2 | Metapneumovirus |
2 | Mental Health |
2 | Membrane Proteins |
2 | Longitudinal Studies |
2 | Leukocytes, Mononuclear |
2 | Kidney |
2 | Intestines |
2 | Internet |
2 | Internationality |
2 | Infant, Newborn |
2 | Immunosuppressive Agents |
2 | Immunoglobulins, Intravenous |
2 | Immunoglobulin Fc Fragments |
2 | Immunization, Secondary |
2 | Immunity, Humoral |
2 | Hypoxia |
2 | Hypertension |
2 | Hydroxychloroquine |
2 | Host Specificity |
2 | Health Behavior |
2 | Haplotypes |
2 | HIV-1 |
2 | HIV Infections |
2 | Glycine |
2 | Glucosephosphate Dehydrogenase Deficiency |
2 | Glomerulosclerosis, Focal Segmental |
2 | Global Health |
2 | Genes, Viral |
2 | Gene Expression Regulation |
2 | Follow-Up Studies |
2 | Fever |
2 | Eutheria |
2 | Epitopes |
2 | Epidemics |
2 | Endosomes |
2 | Cytopathogenic Effect, Viral |
2 | Cytokine Release Syndrome |
2 | Cross-Sectional Studies |
2 | Cross Reactions |
2 | Coronavirus, Bovine |
2 | Convalescence |
2 | Contact Tracing |
2 | Computer Simulation |
2 | Comorbidity |
2 | Clinical Laboratory Techniques |
2 | Cities |
2 | Cell Line, Tumor |
2 | Cattle |
2 | Case-Control Studies |
2 | COVID-19 Testing |
2 | COVID-19 Nucleic Acid Testing |
2 | Bronchitis |
2 | Biomarkers |
2 | Asthma |
2 | Asian Continental Ancestry Group |
2 | Apolipoprotein L1 |
2 | Anxiety |
2 | Age Factors |
2 | 5' Untranslated Regions |
2 | 3' Untranslated Regions |
1 | rab GTP-Binding Proteins |
1 | Zoonoses |
1 | Workload |
1 | Weight Loss |
1 | Water-Electrolyte Balance |
1 | Wastewater-Based Epidemiological Monitoring |
1 | Vomiting |
1 | Viverridae |
1 | Vision Disorders |
1 | Viruses |
1 | Viroporin Proteins |
1 | Viremia |
1 | Viral Regulatory and Accessory Proteins |
1 | Viral Fusion Proteins |
1 | Vietnam |
1 | Vesicular stomatitis Indiana virus |
1 | Vertebrates |
1 | Vaping |
1 | Vaccines, Subunit |
1 | Vaccines, Inactivated |
1 | Vaccines, DNA |
1 | Upper Extremity |
1 | Up-Regulation |
1 | Ubiquitin-Protein Ligases |
1 | Turkeys |
1 | Trinidad and Tobago |
1 | Travel |
1 | Translational Medical Research |
1 | Transfection |
1 | Transduction, Genetic |
1 | Tomography, X-Ray Computed |
1 | Toll-Like Receptor 8 |
1 | Tissue Donors |
1 | Time-to-Treatment |
1 | Thrombotic Microangiopathies |
1 | Thrombocytopenia |
1 | Thermodynamics |
1 | Thalamus |
1 | Thailand |
1 | Texas |
1 | Temperature |
1 | Telemedicine |
1 | Taste Disorders |
1 | Tandem Mass Spectrometry |
1 | Takotsubo Cardiomyopathy |
1 | Taiwan |
1 | Tachycardia |
1 | THP-1 Cells |
1 | T-Lymphocytes, Cytotoxic |
1 | Systemic Inflammatory Response Syndrome |
1 | Switzerland |
1 | Sweden |
1 | Surge Capacity |
1 | Suppressor of Cytokine Signaling 1 Protein |
1 | Structure-Activity Relationship |
1 | Structural Homology, Protein |
1 | State Medicine |
1 | Spleen |
1 | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
1 | Spatio-Temporal Analysis |
1 | Snakes |
1 | Small Molecule Libraries |
1 | Singapore |
1 | Shock, Cardiogenic |
1 | Ships |
1 | Sex Factors |
1 | Sewage |
1 | Serologic Tests |
1 | Sequence Homology, Nucleic Acid |
1 | Sequence Homology, Amino Acid |
1 | Seoul |
1 | Sensitivity and Specificity |
1 | Selenium |
1 | Saccharomyces cerevisiae |
1 | Russia |
1 | Rotavirus |
1 | Ritonavir |
1 | Respiratory Therapy |
1 | Respiratory System |
1 | Respiratory Mucosa |
1 | Respiratory Insufficiency |
1 | Respiratory Function Tests |
1 | Research Design |
1 | Reproducibility of Results |
1 | Repressor Proteins |
1 | Reinfection |
1 | Regulatory Sequences, Ribonucleic Acid |
1 | Regional Health Planning |
1 | Recombinases |
1 | Recombinant Fusion Proteins |
1 | Receptors, Fc |
1 | Reassortant Viruses |
1 | Rats |
1 | Rats, Sprague-Dawley |
1 | ROC Curve |
1 | RNA, Long Noncoding |
1 | RNA Interference |
1 | Quercetin |
1 | Quasispecies |
1 | Quail |
1 | Pyrazoles |
1 | Pulmonary Disease, Chronic Obstructive |
1 | Public Health |
1 | Psychosocial Functioning |
1 | Proventriculus |
1 | Proteome |
1 | Proteolysis |
1 | Protein Subunits |
1 | Protein Structure, Secondary |
1 | Protein Structure, Quaternary |
1 | Protein Processing, Post-Translational |
1 | Protein Isoforms |
1 | Proline |
1 | Principal Component Analysis |
1 | Primate Diseases |
1 | Pregnancy Complications, Infectious |
1 | Postpartum Period |
1 | Posterior Leukoencephalopathy Syndrome |
1 | Portugal |
1 | Polyproteins |
1 | Polyneuropathies |
1 | Poland |
1 | Point-of-Care Systems |
1 | Plasmids |
1 | Plasma Exchange |
1 | Physical Functional Performance |
1 | Physical Distancing |
1 | Phosphorylation |
1 | Phosphoric Triester Hydrolases |
1 | Phosphoproteins |
1 | Peritonsillar Abscess |
1 | Perforin |
1 | Peptides |
1 | Peptide Library |
1 | Peptide Hydrolases |
1 | Patient Care |
1 | Pangolins |
1 | PDZ Domains |
1 | Oxygen |
1 | Oxalates |
1 | Oviducts |
1 | Outpatients |
1 | Organ Specificity |
1 | Ophthalmoplegia |
1 | Ophthalmology |
1 | Ophthalmologists |
1 | Oligodeoxyribonucleotides |
1 | Olfactory Mucosa |
1 | Olfaction Disorders |
1 | Oceania |
1 | Occupational Health |
1 | Obesity |
1 | Nutritional Status |
1 | Nutrigenomics |
1 | Nucleocapsid Proteins |
1 | Nucleic Acid Amplification Techniques |
1 | Newcastle disease virus |
1 | Newcastle Disease |
1 | Neurofilament Proteins |
1 | Neural Conduction |
1 | Nephrosis, Lipoid |
1 | Neoplasms |
1 | Neck Muscles |
1 | Neanderthals |
1 | Naval Medicine |
1 | Mutation Rate |
1 | Mutagenesis, Site-Directed |
1 | Mutagenesis, Insertional |
1 | Mustelidae |
1 | Muscle Weakness |
1 | Multiple Sclerosis |
1 | Multigene Family |
1 | Mothers |
1 | Molecular Structure |
1 | Molecular Probes |
1 | Models, Theoretical |
1 | Models, Statistical |
1 | Models, Chemical |
1 | Minor Histocompatibility Antigens |
1 | Middle East |
1 | Microscopy, Electron |
1 | Microbodies |
1 | MicroRNAs |
1 | Methotrexate |
1 | Metals, Heavy |
1 | Metabolic Networks and Pathways |
1 | Membrane Transport Proteins |
1 | Membrane Microdomains |
1 | Measles virus |
1 | Measles Vaccine |
1 | Malaria |
1 | Magnetic Resonance Imaging |
1 | Macrophages |
1 | Machine Learning |
1 | Macaca mulatta |
1 | Lysosomes |
1 | Lymphohistiocytosis, Hemophagocytic |
1 | Lung Diseases, Interstitial |
1 | Lopinavir |
1 | Loneliness |
1 | Lod Score |
1 | Linear Models |
1 | Leukemia |
1 | Leucovorin |
1 | Length of Stay |
1 | Kidney Glomerulus |
1 | Ion Channels |
1 | Intestinal Mucosa |
1 | Interpersonal Relations |
1 | Internship and Residency |
1 | Intermittent Pneumatic Compression Devices |
1 | Interleukins |
1 | Interferons |
1 | Interferon-gamma |
1 | Interferon Type I |
1 | Intensive Care Units |
1 | Inpatients |
1 | Injections, Subcutaneous |
1 | Injections, Intravenous |
1 | Inhibitory Concentration 50 |
1 | Influenza, Human |
1 | Influenza A virus |
1 | Inflammation |
1 | Infant |
1 | Incidence |
1 | Immunotherapy |
1 | Immunologic Factors |
1 | Immunoglobulins |
1 | Immunocompromised Host |
1 | Immunity, Cellular |
1 | Hypoglossal Nerve Diseases |
1 | Hyperoxaluria |
1 | Host Microbial Interactions |
1 | Hospital Mortality |
1 | Hospital Bed Capacity |
1 | Homozygote |